2022
DOI: 10.1128/spectrum.00192-22
|View full text |Cite
|
Sign up to set email alerts
|

IgA Serological Response for the Diagnosis of Mycobacterium abscessus Infections in Patients with Cystic Fibrosis

Abstract: Mycobacterium abscessus is currently the most frequently isolated rapid growing mycobacterium in human pathology and the major one involved in lung infections. It has recently emerged as responsible for severe pulmonary infections in patients with cystic fibrosis (CF) or those who have undergone lung transplantation.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 23 publications
0
3
0
Order By: Relevance
“…A recent study has shown the utility of serological testing in the detection of culture-positive cases of M. abscessus infection in CF patients [ 90 ]. The test was based on the detection of IgA against M. abscessus protein, recombinant PLC (rPLC), and the TLR2eF extract.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…A recent study has shown the utility of serological testing in the detection of culture-positive cases of M. abscessus infection in CF patients [ 90 ]. The test was based on the detection of IgA against M. abscessus protein, recombinant PLC (rPLC), and the TLR2eF extract.…”
Section: Introductionmentioning
confidence: 99%
“…The test was based on the detection of IgA against M. abscessus protein, recombinant PLC (rPLC), and the TLR2eF extract. This IgA ELISA was able to differentiate M. abscessus from M. avium and M. chimaera infections (but not from M. intracellulare infection) based on the recognition of MABC proteins or extracts, in contrast to the older test which is based on the detection of antibodies recognizing the GPL core antigen of M. avium [ 90 ]. The prevalence of NTM infection in CF patients is currently being tested in a prospective study (clinical study number ID RCB:2017-A00025-48) using both ELISAs.…”
Section: Introductionmentioning
confidence: 99%
“…Serological diagnostic approaches including IgG-and IgAbased ELISA assays have been evaluated for MAC and MABS infection and show early promise. [61][62][63][64][65] Prospective studies involving larger pediatric and adult populations in a range of clinical settings are required to confirm the utility of these tests to aid NTM diagnosis in pwCF.…”
Section: Diagnosis Detection and Screeningmentioning
confidence: 99%